- Current report filing (8-K)
October 13 2010 - 9:45AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
October 13, 2010
CANTEL MEDICAL CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-31337
|
|
22-1760285
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Identification
|
of incorporation)
|
|
File Number)
|
|
Number)
|
150 Clove Road, Little Falls, New Jersey
|
|
07424
|
Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(973) 890-7220
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02
Results of
Operations and Financial Condition
On
October 13, 2010, the Registrant issued a press release announcing its results
of operations for the fourth quarter and fiscal year ended July 31, 2010. A copy of the press release is included with
this Report as Exhibit 99.1.
Item
9.01
Financial
Statements, Pro-Forma Financial Information and Exhibits
(d)
Exhibit 99.1 Press release of Registrant
dated October 13, 2010.
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
CANTEL
MEDICAL CORP.
|
|
|
|
|
|
By:
|
/s/
Andrew A. Krakauer
|
|
|
Andrew
A. Krakauer
|
|
|
President
and CEO
|
|
|
|
Dated:
October 13, 2010
|
|
|
3
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024